Kimia Biosciences Limited (BOM:530313)
India · Delayed Price · Currency is INR 33.29
-3.21 (-8.79%)
At close: Jun 1, 2026
Kimia Biosciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 74.34 | 96.12 | -53.09 | -93.52 | -37.03 |
Depreciation & Amortization | 39.13 | 33.6 | 32.44 | 32.73 | 28.96 |
Other Amortization | - | 0.19 | 0.49 | 0.6 | 0.45 |
Loss (Gain) From Sale of Assets | - | - | - | - | -0.79 |
Loss (Gain) From Sale of Investments | - | - | -0 | -0.03 | -0.02 |
Provision & Write-off of Bad Debts | - | - | - | 2.41 | - |
Other Operating Activities | 42.92 | 75.19 | 26.14 | 10.1 | 17.12 |
Change in Accounts Receivable | 29.44 | -101.36 | 39.15 | 10.81 | 92.51 |
Change in Inventory | 83.25 | -37.8 | 174.3 | -112.16 | -133.31 |
Change in Accounts Payable | -157.59 | 145.64 | -77.14 | 81.37 | 112.09 |
Change in Other Net Operating Assets | -3.05 | 1.56 | 3.06 | - | - |
Operating Cash Flow | 108.44 | 213.14 | 145.35 | -67.7 | 79.97 |
Operating Cash Flow Growth | -49.12% | 46.64% | - | - | 34.02% |
Capital Expenditures | -81.61 | -45.99 | -15.07 | -28.12 | -35.8 |
Sale of Property, Plant & Equipment | - | - | - | - | 20.67 |
Investment in Securities | - | - | 0.63 | - | - |
Other Investing Activities | 0.71 | -1.02 | -0.5 | 0.13 | 8.03 |
Investing Cash Flow | -80.9 | -47.01 | -14.93 | -27.99 | -7.1 |
Short-Term Debt Issued | - | 2.05 | - | 50.22 | - |
Long-Term Debt Issued | 124.39 | 54.04 | 13.4 | 170.42 | 123.43 |
Total Debt Issued | 124.39 | 56.08 | 13.4 | 220.63 | 123.43 |
Short-Term Debt Repaid | -103.77 | - | -0.92 | - | -15.58 |
Long-Term Debt Repaid | - | -164.43 | -107.66 | -97.6 | -150.99 |
Total Debt Repaid | -103.77 | -164.43 | -108.58 | -97.6 | -166.57 |
Net Debt Issued (Repaid) | 20.62 | -108.35 | -95.18 | 123.04 | -43.14 |
Other Financing Activities | -47.04 | -57.2 | -35.54 | -27.62 | -33.54 |
Financing Cash Flow | -26.42 | -165.55 | -130.72 | 95.41 | -76.68 |
Miscellaneous Cash Flow Adjustments | -0.02 | - | - | - | - |
Net Cash Flow | 1.1 | 0.59 | -0.3 | -0.27 | -3.82 |
Free Cash Flow | 26.83 | 167.15 | 130.28 | -95.82 | 44.17 |
Free Cash Flow Growth | -83.95% | 28.30% | - | - | - |
Free Cash Flow Margin | 2.30% | 14.06% | 12.42% | -7.46% | 3.54% |
Free Cash Flow Per Share | 0.59 | 3.53 | 2.75 | -2.02 | 0.93 |
Cash Interest Paid | - | 57.2 | 35.54 | 27.62 | 33.54 |
Cash Income Tax Paid | - | -0.52 | -0.25 | -0.14 | 0.69 |
Levered Free Cash Flow | 31.39 | 54.08 | 114.12 | -67.59 | 56.5 |
Unlevered Free Cash Flow | 53.36 | 76.16 | 141.91 | -44.21 | 75.88 |
Change in Working Capital | -47.95 | 8.04 | 139.37 | -19.98 | 71.28 |